Explore the significance of the AusUDID rollout, its objectives, and how the TGA requirements for UDI differ from FDA regulations.

Explore our library of blogs, short videos, virtual event recordings and training topics
Explore the significance of the AusUDID rollout, its objectives, and how the TGA requirements for UDI differ from FDA regulations.
EUDAMED UDI Compliance is a critical aspect of the European Medical Device Regulation (MDR) that requires...
The Food and Drug Administration (FDA) has implemented the Unique Device Identification (UDI) system to enhance...
What are the potential consequences for medical device manufacturers not following through with product data...
The U.S. Food and Drug Administration (FDA) recently initiated two initiatives to improve the completeness and quality of the Global Unique Device Identification Database (GUDID).
Greetings from Amsterdam! Earlier this month, Sales Development Representative Miriam Kniering represented Reed Tech...
Horsham, Pa., USA – May 25, 2023The collaboration of the leading providers of Unique Device Identification (UDI) for...
In the latest edition of 'Coffee Talk', Reed Tech UDI experts, Gary Saner (Sr. Manager of Information Solutions) and...
Pharma manufacturers and authorized distributors need to submit distribution reports electronically in an eXtensible Markup Language (XML) format to comply with the guidance entitled Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act. This guidance fulfills the Drug Sample Transparency Act specification of ACA Section 6004. These amounts must be reported each year by April 1st for the previous calendar year.